Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) sits in the top decile of US sponsors by registered trial count (#116 of 15,742 sponsors by registered trial count).

305 total trials 24 currently recruiting 252 completed early-phase tilt top decile by trial count

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD): 305 sponsored US clinical trials, 24 recruiting.

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) sponsors 305 registered US clinical trials on ClinicalTrials.gov, 24 of them currently recruiting, and 252 completed. 35 of these trials are in Phase 3-4 (later-stage) and 89 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Pregnancy, with 8 trials.

Top-decile sponsor footprint

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) ranks in the top decile of sponsors by registered trial count (#116 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 66/100

252 of 279 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

305 total, page 1 of 7

RECRUITING

Turner Syndrome: Genetic Considerations

NCT07502586

RECRUITING

Identifying Genome Variants in Non-Obstructive Azoospermia (NOA) or Primary Ovarian Insufficiency (POI)

NCT07357701

RECRUITING Phase 3

Hormone Replacement Therapy in Adolescents With Premature Ovarian Insufficiency

NCT06851754

RECRUITING

Uncovering Genes Behind Cartilage Tumors and Vascular Anomalies Using Genomic Sequencing

NCT06749366

RECRUITING

MEHMO Natural History and Biomarkers

NCT06019182

RECRUITING

A Prospective Natural History Study of Lymphatic Anomalies

NCT05731141

RECRUITING

Establishment of Genomic and Phenotypic Database for Niemann-Pick Disease, Type C

NCT05588167

RECRUITING

Characterization of Dysmorphology in Subjects With Creatine Transporter Deficiency

NCT05600946

RECRUITING

Development of a Wearable Point of Care Monitoring Device for Pediatric Obstructive Sleep Apnea

NCT05052216

RECRUITING

Biorepository in Participants Who Undergo OTC for Gonadotoxic Therapy

NCT05440617

RECRUITING

Study of Skeletal Disorders

NCT05031507

RECRUITING

Gonadal Tissue Freezing for Fertility Preservation in Individuals at Risk for Ovarian Dysfunction, Premature Ovarian Insufficiency and Clinically Indicated Gonadectomy

NCT04948658

RECRUITING

Biochemical and Phenotypical Aspects of Smith-Lemli-Opitz Syndrome and Related Disorders of Cholesterol Metabolism

NCT05047354

RECRUITING

Androgen Receptor, Implications for Health and Wellbeing: Natural History Study of Individuals With Androgen Insensitivity

NCT04708431

RECRUITING

Data Collection Study of Pediatric and Adolescent Gynecology Conditions

NCT04717349

RECRUITING

Long-Term Follow-Up of Survivors of Pediatric Cushing Disease

NCT03831958

RECRUITING

Mirror Neuron Network Dysfunction as an Early Biomarker of Neurodevelopmental Disorder

NCT03307317

RECRUITING

Investigations of Juvenile Neuronal Ceroid Lipofuscinosis

NCT03307304

RECRUITING

Evaluation of Children With Endocrine and Metabolic-Related Conditions

NCT02769975

RECRUITING

Children s Growth and Behavior Study

NCT02390765

RECRUITING

Evaluation of Biochemical Markers and Clinical Investigation of Niemann-Pick Disease, Type C

NCT00344331

RECRUITING

Natural History Study of Patients With Excess Androgen

NCT00250159

RECRUITING Phase 1

Diagnosis of Pheochromocytoma

NCT00004847

RECRUITING

An Investigation of Pituitary Tumors and Related Hypothalmic Disorders

NCT00001595

ACTIVE NOT RECRUITING

The Developmental Origins of Suicide Mortality

NCT03027440

ACTIVE NOT RECRUITING

Skeletal Muscle Biomarkers in People With Fragile Sarcolemmal Muscular Dystrophy

NCT01851447

COMPLETED

Speckle Plethysmography Pulse Transit Time as a Marker of Blood Pressure Changes

NCT05554315

COMPLETED

Functional Near-Infrared Spectroscopy (fNIRS) Combined With Diffuse Correlation Spectroscopy (DCS) in Neurocognitive Disease as Compared to Healthy Neurotypical Controls

NCT05642221

TERMINATED NA

Study of Pregnancy And Neonatal Health (SPAN)

NCT05515744

TERMINATED

Endometrial Basis for Infertility in Women With Recurrent Implantation Failure and Pregnancy Loss

NCT04939064

COMPLETED

Fertility Attitudes of Adolescents and Young Adults With Turner Syndrome and Their Parents/Guardians (The Fertility ConcepTS Study)

NCT05078892

COMPLETED NA

A Noninvasive Multimodal Biosensing Device for Screening and Monitoring Response to Treatment of Infectious Respiratory Diseases

NCT05035420

COMPLETED Phase 2

Colchicine to Suppress Inflammation and Improve Insulin Resistance in Adults and Adolescents With Obesity

NCT05017571

TERMINATED NA

Optic-to-Audio Device in a Pediatric Cohort With CLN3-related Conditions or Low Vision

NCT04974307

COMPLETED Phase 2

Liraglutide (Saxenda(R)) in Adolescents With Obesity After Sleeve Gastrectomy

NCT04883346

TERMINATED Phase 1

Combined Intrathecal and Intravenous VTS-270 Therapy for Liver and Neurological Disease Associated With Niemann-Pick Disease, Type C1

NCT03887533

COMPLETED Phase 3

Safety and Efficacy of Pegvisomant in Children With Growth Hormone Excess

NCT03882034

COMPLETED

Natural History of the Collagen-Related Disorder Osteogenesis Imperfecta and Genotype Phenotype Correlation

NCT03575221

COMPLETED

Biomarkers in Obstetrical Complications

NCT03480139

COMPLETED

PregSource: Crowdsourcing to Understand Pregnancy

NCT02577536

COMPLETED Phase 2

Break It Up: A Study Evaluating Breaking Up Daily Sedentary Behavior in Youth

NCT03223649

COMPLETED NA

Mobile Attention Retraining in Overweight Female Adolescents

NCT02977403

COMPLETED

Pediatric Patients With Metabolic or Other Genetic Disorders

NCT02769949

COMPLETED NA

Determining Age Appropriateness of Children's Products and Toys

NCT02544035

TERMINATED

Psychological Outcomes in Isolated GnRH Deficiency

NCT02356172

TERMINATED

Genetic Causes of Growth Disorders

NCT02311322

COMPLETED

Pregnancy Eating Attributes Study

NCT02217462

COMPLETED

Fertility Preservation in Women Who Will Have Gonadotoxic Therapy or Hematopoetic Stem Cell Transplantation, and in Women With Sickle Cell Disease

NCT02225145

COMPLETED

Clinical Biomarkers in Alpha-mannosidosis

NCT02141503

TERMINATED Phase 1

Deep Reading as a Contemplative Practice for Women With Primary Ovarian Insufficiency

NCT02181595

Page 1 of 7 Next →

Phase Distribution

PhaseTrial count
Phase 1 40
Phase 2 49
Phase 3 23
Phase 4 12

What is open in the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) pipeline

24 recruiting of 305 indexed (8% open); 252 completed (83%).

Phase mix: 35 late (III/IV) vs 89 early (I/II) (early-phase heavy).

Top condition: Pregnancy (8 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD): open-pipeline peers nationwide

Peers matched on 305 registered trials and 8% open enrollment, not the therapeutic-area sidebar.

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 02004006008001,000 0%5%10%15% Total trials Recruiting share Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)CelgeneAllerganKaiser PermanenteUniversity of ArkansasBoston Scientific CorporationNovo Nordisk A/SHoffmann-La RocheUnited Therapeutics
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 305 trials (± recruiting share)

Sponsors near 8% open enrollment (± trial volume)

What to do with this Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) page

305 registered trials is a research-attention snapshot, not an endorsement of Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) or any single study.

  • 24 of Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)'s trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Pregnancy is the condition Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Pregnancy trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) pipeline card: 305 registered trials from official public datasets.Report a data error.